Ameresco, Inc.
NYSEAMRC fell more than 10% on Tuesday — its worst single session in months — creating a sharp divergence between a bearish analyst call and a founder who has been buying stock almost every week. The session loss arrived alongside a Baird downgrade. Analyst Ben Kallo cut his rating to Neutral from Outperform and trimmed his target to $32 from $36 — a meaningful pivot from a firm that…
Snapshot as of 19 Aug 2026
AMRC fell more than 10% on Tuesday — its worst single session in months — creating a sharp divergence between a bearish analyst call and a founder who has been buying stock almost every week. The session loss arrived…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMRC — free to start on ORTEX.
Sign up for free →Open AMRC on ORTEX